Hepatoblastoma exhibited significantly higher levels of cholesterol synthase (SREBF2, SQLE, HMGCS1) compared to normal liver tissues, which indicated higher metabolic activity (Figure 3H). This evidence concerns the gene HMGCS1 and hepatoblastoma.